Immunosuppressed Transplant Recipient Recovers from COVID-19
Implications of COVID-19 for transplant recipients and immunosuppressed patients with insights from Professor of Surgery Dr. Gang Chen MD.
Transplantation
NuVasive Announces Publication Demonstrating Efficacy of Synthetic Putty in Lumbar Fusion
NuVasive, Inc. (Nasdaq: NUVA) has announced a recent publication demonstrating the efficacy of their synthetic bioactive putty in lumbar fusion.
Limited Efficacy of Immunosuppressive Strategy in Transplant Patients Associated with Immunoproteosome
The limited efficacy of a proteosome inhibitor-based immunosuppressive strategy in highly HLA-sensitized transplant recipients has been associated with the immunoproteosome.
Therapy for Steroid-Refractory and/or Resistant GvHD Favorably Alters White Blood Cell Profile
A therapy for steroid-refractory and/or resistant GvHD may function by favorably altering a population of circulating white blood cells.
Immune Biomarker May Predict Kidney Transplant Rejection Prior to Surgery
The expression level of the protein Interleukin-21 in circulating immune cells may serve as a biomarker for kidney transplant rejection.
Possible Combination Therapy for Sensitized Kidney Transplant Recipients Harnesses Existing Cancer Drug
A combinationm therapy involving an existing cancer drug and costimulation blockade has shown promise for sensitized kidney transplant recipients.
Role Identified for Complement Receptor in Heart Transplant Rejection
A cell surface receptor for a protein associated with the innate immune system known as a complement receptor has recently been demonstrated to be important for the prevention of heart transplant rejection in mice.